Concepedia

Marinda Meertens

MM

Statistics

Publications

4

Citations

105

H-Index

4

Active since

2022

Affiliations

Princess Máxima Center(Current)

The Netherlands Cancer Institute

University Medical Center Utrecht

Utrecht University

Erasmus MC Cancer Institute

Marinda Meertens is an author at Princess Máxima Center specializing in oncology, oncology pharmacology, and therapeutic drug monitoring.

Publications per year

2022–2024

4

Publications

4

Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study

Stefanie L. Groenland, Ruben A.G. van Eerden, Kim Westerdijk et al. · Annals of Oncology · 2022 · 75 citations · Full text

Medicine, Oncology, Pharmacology +16

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

Marinda Meertens, M Benthe Muntinghe-Wagenaar, Barend J. Sikkema et al. · Frontiers in Oncology · 2023 · 10 citations · Full text

Medicine, Oncology, Pharmacology +15

Analytical Validation of a Volumetric Absorptive Microsampling Method for Therapeutic Drug Monitoring of the Oral Targeted Anticancer Agents, Abiraterone, Alectinib, Cabozantinib, Imatinib, Olaparib, and Sunitinib, and Metabolites

Marinda Meertens, Niels de Vries, Hilde Rosing et al. · Therapeutic Drug Monitoring · 2024 · 10 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study

Maud B. A. van der Kleij, Niels A.D. Guchelaar, Marinda Meertens et al. · British Journal of Cancer · 2024 · 10 citations · Full text

Pharmacy, Oncology, Pharmacology +13

1–4 of 4